GlassScriptPhysician profile
Julia V Adrogue
NPI 1659510196
$8,804.58
in general payments reported to CMS, 2019-2025
44 companies · $1,185 in 2025
The $1,185 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $836 · 2020: $932 · 2021: $1,031 · 2022: $1,299 · 2023: $2,019 · 2024: $1,502 · 2025: $1,185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,690 · Education: $17.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,689.50 |
| Education | $17.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $823.09 | 2019-2023 | Xarelto |
| Abbott Laboratories | $718.17 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Mitraclip, Cardiomems |
| Artivion, INC. | $711.96 | 2020 | |
| Amgen INC. | $693.57 | 2019-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $635.44 | 2021-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $547.06 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $499.59 | 2019-2025 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $462.34 | 2019-2025 | Lifevest |
| Cvrx, INC. | $362.92 | 2022-2024 | Barostim Neo System |
| Medtronic, INC. | $353.87 | 2023-2025 | Corevalve Evolut R, Harmony |
| Boston Scientific Corporation | $322.42 | 2019-2025 | Watchman Flx, Bodyguardian, Watchman Access System |
| Sanofi-Aventis U.S. LLC | $282.52 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $238.71 | 2021-2024 | Jardiance |
| Impulse Dynamics (USA) INC. | $213.28 | 2022-2024 | Optimizer, Optimizer |
| Heartflow, INC. | $209.62 | 2019-2025 | Ffrct |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Adrogue listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.